Market Overview:
The global continuous glucose monitoring devices market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in continuous glucose monitoring devices, and rising awareness about diabetes management. Based on type, the global continuous glucose monitoring devices market is segmented into sensors, transmitters & receivers, and insulin pumps. The sensors segment is expected to account for the largest share of the global market in 2018. This can be attributed to the increasing demand for minimally invasive blood sugar testing methods and growing preference for sensor-based systems over traditional blood sugar meters. Based on application, the global continuous glucose monitoring devices market is segmented into diabetic patients and healthy individuals.
Product Definition:
Continuous Glucose Monitoring Devices measure glucose levels in the body on a continuous basis. They are important for people with diabetes because they help to ensure that blood sugar levels remain stable and within target range. CGMs can also help to identify and prevent dangerous high or low blood sugar episodes.
Sensors:
Sensors are devices that detect or measure some physical phenomenon and convert the information into signals. Sensors are used in various applications such as chemical, biological, mechanical, thermal and optical. The major types of sensors include photoelectric sensors, capacitive sensors (for touch), resistive/inductive sensors (for sound), thermocouples (temperature measurement) and nuclear magnetic resonance (NMR) scanners.
Transmitters & Receivers:
The global Transmitters & Receivers and it's usage in Continuous Glucose Monitoring devices market size was valued at USD 1.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing demand for continuous glucose monitoring (CGM) devices by patients suffering from diabetes is one of the major factors driving growth during the forecast period.
Application Insights:
The diabetic patients segment dominated the global market in 2017. This can be attributed to the increasing prevalence of diabetes and rising demand for CGM devices among this population. For instance, as per U.S. National Library of Medicine National Institutes of Health, around 30 million individuals in America suffer from diabetes and its incidence is increasing rapidly due to obesity and Inactivity which causes insulin resistance leading to type 2 diabetes mellitus (T2DM). Hence, there is a huge potential market for continuous glucose monitoring devices among T2DM patients globally which will boost product demand over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of manufacturers and distributors, availability of advanced products, high awareness levels coupled with high healthcare expenditure levels in this region. Moreover, reimbursement policies for CGM systems are more favorable in North America than other regions. For instance, under Medicare Part B coverage is given to patients suffering from diabetes if they are using a sensor-based system such as G6 smartpen or Nova Max Plus insulin pump.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing product penetration and rising patient awareness regarding these systems along with their benefits such as reduced dosage requirement and no needle stick risk associated with them. In addition, an increase in disposable income will boost demand for these devices further over the forecast period In Japan; around 30 million people suffer from diabetes out of which 90% have type 2 whereas 10% has type 1 (Barcia et al., 2015).
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is expected to drive the demand for continuous glucose monitoring devices in the coming years.
- Rising awareness about benefits of continuous glucose monitoring: There is a growing awareness among people about the benefits of using continuous glucose monitoring devices. This is likely to boost the demand for these devices in the near future.
- Technological advancements: Continuous glucose monitoring devices are constantly evolving with new and innovative technologies being introduced into the market on a regular basis. This is likely to fuel their growth in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Continuous Glucose Monitoring Devices Market Research Report
By Type
Sensors, Transmitters & Receivers, Insulin Pumps
By Application
Diabetic Patients, Healthy Individuals
By Companies
Abbott Laboratories, Echo Therapeutics, Inc., Dexcom, Inc., GlySens Incorporated, Medtronic plc, Senseonics Holdings, Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AgaMatrix, Inc., Glucovation, GlySure, Arkray USA, Inc., OrSense
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Continuous Glucose Monitoring Devices Market Report Segments:
The global Continuous Glucose Monitoring Devices market is segmented on the basis of:
Types
Sensors, Transmitters & Receivers, Insulin Pumps
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diabetic Patients, Healthy Individuals
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Echo Therapeutics, Inc.
- Dexcom, Inc.
- GlySens Incorporated
- Medtronic plc
- Senseonics Holdings, Inc.
- Johnson & Johnson
- F. Hoffmann-La Roche Ltd.
- AgaMatrix, Inc.
- Glucovation
- GlySure
- Arkray USA, Inc.
- OrSense
Highlights of The Continuous Glucose Monitoring Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sensors
- Transmitters & Receivers
- Insulin Pumps
- By Application:
- Diabetic Patients
- Healthy Individuals
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Continuous Glucose Monitoring Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Continuous glucose monitors (CGM) are devices that measure blood sugar levels continuously and send the data to a receiver. CGM can help people with diabetes manage their blood sugar levels more effectively by helping them learn how their blood sugar is changing over time, and providing feedback on whether they are meeting their goals.
Some of the key players operating in the continuous glucose monitoring devices market are Abbott Laboratories, Echo Therapeutics, Inc., Dexcom, Inc., GlySens Incorporated, Medtronic plc, Senseonics Holdings, Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AgaMatrix, Inc., Glucovation, GlySure, Arkray USA, Inc., OrSense.
The continuous glucose monitoring devices market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Continuous Glucose Monitoring Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Continuous Glucose Monitoring Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Continuous Glucose Monitoring Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Continuous Glucose Monitoring Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Continuous Glucose Monitoring Devices Market Size & Forecast, 2018-2028
4.5.1 Continuous Glucose Monitoring Devices Market Size and Y-o-Y Growth
4.5.2 Continuous Glucose Monitoring Devices Market Absolute $ Opportunity
Chapter 5 Global Continuous Glucose Monitoring Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Continuous Glucose Monitoring Devices Market Size Forecast by Type
5.2.1 Sensors
5.2.2 Transmitters & Receivers
5.2.3 Insulin Pumps
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Continuous Glucose Monitoring Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Continuous Glucose Monitoring Devices Market Size Forecast by Applications
6.2.1 Diabetic Patients
6.2.2 Healthy Individuals
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Continuous Glucose Monitoring Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Continuous Glucose Monitoring Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Continuous Glucose Monitoring Devices Analysis and Forecast
9.1 Introduction
9.2 North America Continuous Glucose Monitoring Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Continuous Glucose Monitoring Devices Market Size Forecast by Type
9.6.1 Sensors
9.6.2 Transmitters & Receivers
9.6.3 Insulin Pumps
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Continuous Glucose Monitoring Devices Market Size Forecast by Applications
9.10.1 Diabetic Patients
9.10.2 Healthy Individuals
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Continuous Glucose Monitoring Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Continuous Glucose Monitoring Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Continuous Glucose Monitoring Devices Market Size Forecast by Type
10.6.1 Sensors
10.6.2 Transmitters & Receivers
10.6.3 Insulin Pumps
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Continuous Glucose Monitoring Devices Market Size Forecast by Applications
10.10.1 Diabetic Patients
10.10.2 Healthy Individuals
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Continuous Glucose Monitoring Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Continuous Glucose Monitoring Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Continuous Glucose Monitoring Devices Market Size Forecast by Type
11.6.1 Sensors
11.6.2 Transmitters & Receivers
11.6.3 Insulin Pumps
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Continuous Glucose Monitoring Devices Market Size Forecast by Applications
11.10.1 Diabetic Patients
11.10.2 Healthy Individuals
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Continuous Glucose Monitoring Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Continuous Glucose Monitoring Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Continuous Glucose Monitoring Devices Market Size Forecast by Type
12.6.1 Sensors
12.6.2 Transmitters & Receivers
12.6.3 Insulin Pumps
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Continuous Glucose Monitoring Devices Market Size Forecast by Applications
12.10.1 Diabetic Patients
12.10.2 Healthy Individuals
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Continuous Glucose Monitoring Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Continuous Glucose Monitoring Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Continuous Glucose Monitoring Devices Market Size Forecast by Type
13.6.1 Sensors
13.6.2 Transmitters & Receivers
13.6.3 Insulin Pumps
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Continuous Glucose Monitoring Devices Market Size Forecast by Applications
13.10.1 Diabetic Patients
13.10.2 Healthy Individuals
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Continuous Glucose Monitoring Devices Market: Competitive Dashboard
14.2 Global Continuous Glucose Monitoring Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Echo Therapeutics, Inc.
14.3.3 Dexcom, Inc.
14.3.4 GlySens Incorporated
14.3.5 Medtronic plc
14.3.6 Senseonics Holdings, Inc.
14.3.7 Johnson & Johnson
14.3.8 F. Hoffmann-La Roche Ltd.
14.3.9 AgaMatrix, Inc.
14.3.10 Glucovation
14.3.11 GlySure
14.3.12 Arkray USA, Inc.
14.3.13 OrSense
